BDX
Price
$218.03Alerts
Change
+$2.32 (+1.08%)
Updated
Nov 13 closing price
Capitalization
57.71B
80 days until earnings call
Intraday BUY SELL Signals
BMED
Price
$36.32Alerts
Change
-$0.12 (-0.33%)
Updated
Nov 13 closing price
Net Assets
14.56M
Intraday BUY SELL Signals
Interact to see
Advertisement

BDX vs BMED

BDX vs BMED Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
BDX vs. BMED commentary
Nov 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDX is a Buy and BMED is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for BDX with price predictions
Nov 13, 2026

BDX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BDX turned positive on October 09, 2026. Looking at past instances where BDX's MACD turned positive, the stock continued to rise in 26 of 47 cases over the following month. The odds of a continued upward trend are 55%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 12, 2026. You may want to consider a long position or call options on BDX as a result. In 55 of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 54%.

The 10-day moving average for BDX crossed bullishly above the 50-day moving average on October 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 44%.

Following a +1.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where BDX advanced for three days, in 136 of 296 cases, the price rose further within the following month. The odds of a continued upward trend are 46%.

The Aroon Indicator entered an Uptrend today. In 115 of 219 cases where BDX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 42%.

BDX broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 3 (best 1 - 100 worst), indicating outstanding price growth. BDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.364) is normal, around the industry mean (4.964). P/E Ratio (63.819) is within average values for comparable stocks, (40.591). Projected Growth (PEG Ratio) (1.107) is also within normal values, averaging (4.143). BDX has a moderately high Dividend Yield (0.020) as compared to the industry average of (0.005). P/S Ratio (2.290) is also within normal values, averaging (56.876).

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 85 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for BMED with price predictions
Nov 13, 2026

BMED sees MACD Histogram just turned negative

BMED saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 46 instances where the indicator turned negative. In 36 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 78%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BMED moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator moved out of overbought territory. In 24 of the 35 cases, the stock moved lower in the following days. This puts the odds of a move lower at 69%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 49 of 66 cases where BMED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 74%.

The Momentum Indicator moved below the 0 level on November 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMED as a result. In 72 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMED declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 77%.

BMED broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

Following a +3.57% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMED advanced for three days, in 223 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

The Aroon Indicator entered an Uptrend today. In 216 of 281 cases where BMED Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 77%.

FUNDAMENTALS RATINGS
BDX: Fundamental Ratings
BDX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
PROFIT vs RISK RATING
1..100
57
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
3
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDXBMED
RSI
ODDS (%)
Bearish Trend 3 days ago
71%
Bearish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
48%
Bearish Trend 3 days ago
74%
Momentum
ODDS (%)
Bullish Trend 5 days ago
54%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 6 days ago
55%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
52%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
46%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
42%
Bearish Trend 3 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
53%
Bearish Trend 3 days ago
64%
Aroon
ODDS (%)
Bullish Trend 3 days ago
53%
Bullish Trend 3 days ago
77%
COMPARISON
Comparison
Nov 16, 2026
Stock price -- (BDX: $218.03)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDX’s FA Score shows that 2 FA rating(s) are green while .

  • BDX’s FA Score: 2 green, 3 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDX’s TA Score shows that 5 TA indicator(s) are bullish.

  • BDX’s TA Score: 5 bullish, 4 bearish.

Price Growth

BDX (@Pharmaceuticals: Other) experienced а +2.90% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.79%. For the same industry, the average monthly price growth was +4.31%, and the average quarterly price growth was +18.71%.

Reported Earning Dates

BDX is expected to report earnings on Feb 04, 2027.

Industries' Descriptions

@Pharmaceuticals: Other (+1.79% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
Interact to see
Advertisement

BDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDX has been loosely correlated with COO. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BDX jumps, then COO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDX
1D Price
Change %
BDX100%
+1.08%
COO - BDX
52%
Loosely correlated
+0.74%
MMSI - BDX
50%
Loosely correlated
-0.07%
TMO - BDX
50%
Loosely correlated
+0.11%
BAX - BDX
49%
Loosely correlated
+0.27%
RMD - BDX
48%
Loosely correlated
+0.27%
More

BMED and

Correlation & Price change

A.I.dvisor tells us that BMED and CRL have been poorly correlated (+16% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMED and CRL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMED
1D Price
Change %
BMED100%
-0.34%
CRL - BMED
16%
Poorly correlated
-0.83%
BDX - BMED
15%
Poorly correlated
+1.08%
MCRB - BMED
13%
Poorly correlated
-0.71%
GKOS - BMED
13%
Poorly correlated
-0.13%
VRTX - BMED
13%
Poorly correlated
-0.74%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BG101.651.67
+1.67%
Bunge Global SA
DOYU3.840.03
+0.79%
DouYu International Holdings Limited
FRSH12.67N/A
N/A
Freshworks
WXM2.68-0.05
-2.01%
WF International Limited
DBVT11.02-0.42
-3.63%
DBV Technologies S.A